Cian Healthcare
5.62
-5.62(-100.00%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-100.00%
1M-100.00%
6M-100.00%
1Y-100.00%
5Y-100.00%
View Company Insightsright
More news about Cian Healthcare
06Aug 25
Cian Healthcare's Insolvency Resolution Plan Advances to NCLT Hearing on August 22, 2025
Cian Healthcare, undergoing Corporate Insolvency Resolution Process (CIRP), has its approved resolution plan scheduled for a hearing before the NCLT Mumbai Bench on August 22, 2025. The plan was approved by the Committee of Creditors on May 9, 2025, and submitted to NCLT on May 23, 2025. The company continues to comply with SEBI regulations by providing timely updates on the CIRP proceedings.
05Aug 25
Cian Healthcare's Insolvency Resolution Plan Hearing Scheduled for August 6, 2025
Cian Healthcare Limited, under insolvency proceedings, announced that the National Company Law Tribunal (NCLT) will consider the approval of its resolution plan on August 6, 2025. The plan, approved by the Committee of Creditors on May 9, 2025, was submitted to NCLT on May 23, 2025. Resolution Professional Roshen Chordiya confirmed these developments in a regulatory filing, emphasizing the company's commitment to transparency and compliance with SEBI regulations.
Cian Healthcare
5.62
-5.62
(-100.00%)
1 Year Returns:-100.00%
Industry Peers
Windlas Biotech
790.15
(+0.55%)
Jeena Sikho Lifecare
699.20
(+0.52%)
Blue Jet Healthcare
554.80
(-2.56%)
Abbott
28,850.00
(-0.14%)
Sunrest Lifescience
42.05
(-2.21%)
Zenith Drugs
54.60
(+2.25%)
Pfizer
5,001.00
(+0.57%)
FDC
414.10
(+0.24%)